Engineered Bone Marrow Stem Cell-Sheets Alleviate Renal Damage in a Rat Chronic Glomerulonephritis Model

Area of Science:

• Regenerative Medicine
• Nephrology
• Biotechnology

Background:

• Mesenchymal stem cell (MSC) therapy shows promise for kidney diseases, but cell delivery and engraftment remain challenges.
• Cell sheet technology offers improved transplantation efficiency by preserving cell adhesion proteins.
• This study investigates the therapeutic potential of MSC sheets for chronic kidney disease.

Purpose of the Study:

• To evaluate the efficacy of rat bone marrow stem cell (rBMSC) sheet transplantation in a rat model of chronic glomerulonephritis.
• To assess the impact of MSC sheets on kidney fibrosis, inflammation, oxidative stress, and regeneration.

Main Methods:

• Chronic glomerulonephritis was induced in rats using anti-Thy 1.1 antibody (OX-7).
• rBMSC sheets were prepared using temperature-responsive surfaces and transplanted onto rat kidneys.
• Therapeutic effects were evaluated at 4 weeks post-transplantation, assessing proteinuria, extracellular matrix deposition, gene expression, and injury markers.

Main Results:

• MSC sheet transplantation led to significant reductions in proteinuria and glomerular extracellular matrix deposition.
• The treatment ameliorated podocyte and renal tubular injury, indicated by normalized expression of key markers.
• MSC sheets enhanced regenerative factor expression and reduced markers of inflammation, oxidative stress, and fibrosis.

Conclusions:

• MSC sheets facilitate efficient cell transplantation and function, effectively retarding progressive renal fibrosis.
• The therapeutic benefits are mediated through paracrine actions, including anti-inflammatory, anti-oxidative stress, and anti-apoptotic effects.
• MSC sheet technology represents a promising approach for enhancing regenerative therapy in kidney disease.